인쇄하기
취소
|
Due to the aggressiveness of the pharmaceutical distribution industry, it is reported that multinational pharmaceutical companies actively consider raising the distribution costs.
The report has drawn attention on the last 7th after the Korean branch of GlaxoSmithKline (hereinafter referring to GSK) agreed on the agenda to increase distribution costs due to the aggressiveness of distribution c...